Abstract-Respiratory disturbances are a primary phenotype of the neurological disorder, Rett syndrome (RTT), caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Mouse models generated with null mutations in Mecp2 mimic respiratory abnormalities in RTT girls. Large deletions, however, are seen in only $10% of affected human individuals. Here we characterized respiration in heterozygous females from two mouse models that genetically mimic common RTT point mutations, a missense mutation T158A (Mecp2 T158A/+ ) or a nonsense mutation R168X (Mecp2
Abstract-Respiratory disturbances are a primary phenotype of the neurological disorder, Rett syndrome (RTT), caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Mouse models generated with null mutations in Mecp2 mimic respiratory abnormalities in RTT girls. Large deletions, however, are seen in only $10% of affected human individuals. Here we characterized respiration in heterozygous females from two mouse models that genetically mimic common RTT point mutations, a missense mutation T158A (Mecp2 T158A/+ ) or a nonsense mutation R168X (Mecp2
R168X/+
). MeCP2 T158A shows decreased binding to methylated DNA, while MeCP2 R168X retains the capacity to bind methylated DNA but lacks the ability to recruit complexes required for transcriptional repression. We found that both Mecp2 T158A/+ and Mecp2 R168X/+ heterozygotes display augmented hypoxic ventilatory responses and depressed hypercapnic responses, compared to wild-type controls. Interestingly, the incidence of apnea was much greater in Mecp2
INTRODUCTION
Rett syndrome (RTT) is a neurological disorder that affects approximately 1 in 10,000 girls. It is caused by mutations in the X-linked gene encoding methyl-CpGbinding protein 2 (MeCP2), a modulator of gene transcription (Amir et al., 1999; Guy et al., 2011) . To date, more than 200 different mutations in MECP2 have been identified in RTT cases (Van den Veyver and Zoghbi, 2001; Bienvenu and Chelly, 2006) . The majority of these, however, are point mutations clustered within or near one of three conserved functional domains of MeCP2 (the methyl-CpG binding domain [MBD] , the nuclear localization signals [NLS] , and the transcriptional repression domain [TRD] ) suggesting the importance of these domains in protein function.
Respiratory abnormalities, characterized by frequent apnea and an irregular inter-breath interval, are a main phenotype of RTT (Katz et al., 2009; Ramirez et al., 2013) . Thus far, the majority of respiratory studies in mouse models of RTT have utilized males with Mecp2 null mutations. While this strategy avoids the issue of mosaic expression of MeCP2 due to random X-inactivation, it does not address the fact that patients with the disorder are almost exclusively heterozygous females; hemizygous male patients typically die in utero or shortly thereafter (Bienvenu and Chelly, 2006) . Respiratory studies in Mecp2 deficient female mice (Mecp2 À/+ ) have, to date, been confined to animals with deletions of exons III and IV (referred to as Mecp2 Bird ) (Bissonnette and Knopp, 2006; Abdala et al., 2010; Samaco et al., 2013) or exon III (referred to as Mecp2 Jae ) (Schmid et al., 2012) . These large deletions, however, are seen in only $10% of affected individuals . Animal models of RTT are important tools for preclinical studies; therefore, it is desirable to expand investigations to include the respiratory phenotype of RTT mouse models with common RTT mutations. In doing so, we gain a better understanding of which breathing abnormalities are most robustly affected across mutation types. In addition, these studies may provide insight into how different MeCP2 domains contribute to respiratory phenotypes in RTT and how different RTT mutations impair the functional domains of MeCP2.
In this study, we characterized the respiratory phenotype of two mouse models whose mutations are among two of the eight most commonly found in human cases of RTT (Colvin et al., 2004; Archer et al., 2007; Bebbington et al., 2008; Neul et al., 2008 Abbreviations: EPSCs, excitatory post-synaptic currents; MBD, methylCpG-binding domain; MeCP2, methyl-CpG-binding protein 2; NLS, nuclear localization signals; NMDA, N-methyl-D-aspartic acid; NTS, nucleus tractus solitarius; PHFD, post-hypoxic decline in respiratory frequency; RTT, Rett syndrome; T E , expiratory time; T I , inspiratory time; T TOT , total respiratory time; TRD, transcriptional repression domain; V T , tidal volume; XCI, X-chromosome inactivation.
Neuroscience 267 (2014) [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] mouse model, conversion of threonine 158 to methionine or alanine (T158M or T158A) results in a mutated protein with decreased binding to methylated DNA and that is degraded more rapidly than normal MeCP2 (Goffin et al., 2011) . In the second model, a knockin of a stop codon at arginine 168, mimicking a nonsense R168X mutation, yields an early truncated MeCP2 protein that retains the MBD domain, but the TRD domain is lost (Brendel et al., 2007; Lawson-Yuen et al., 2007) . We characterized the respiratory patterns in female heterozygotes with either the MeCP2 T158A (Mecp2 T158A/+ ) or MeCP2 R168X (Mecp2 R168X/+ ) mutation. In addition, it has previously been shown that Mecp2 deficient mice have an augmented ventilatory response to hypoxia (Bissonnette and Knopp, 2006; Voituron et al., 2009; Ward et al., 2011 ) and a depressed carbon dioxide chemosensitivity Toward et al., 2013 -Yuen et al., 2007) were a kind gift from Joanne E Berger-Sweeney at the Tufts University. These mice were on a mixed C57Bl/6 Â 129S6/SvEv Tac background.
Plethysmography
Respiratory frequency, tidal volume (V T ) and their product minute ventilation (VE) were determined in a body plethysmograph (Mortola and Noworaj, 1983; Bissonnette and Knopp, 2006) . Briefly, individual unanesthetized animals were placed in a 65 mL chamber with their heads exposed through a close fitting hole in Parafilm Ò . A pneumotachograph (Mortola and Noworaj, 1983 ) was connected to the chamber and a differential pressure transducer (Model PT5A, Grass Instrument Co., West Warick, RI, USA). The pressure signal was integrated to give V T . Volume changes were calibrated by injecting known amounts of air into the chamber. The analog signal from the transducer was amplified, converted to digital, displayed on a monitor, and stored to disc by computer for later analysis. The studies were begun after the animal was given time to become adjusted to the chamber. A cone was fitted over the animal's head that allowed inspired gases to be delivered. For hypoxia experiments gas at the nose was rapidly, in 5 s, changed in succession from air to 8% O 2 for 5 min and then returned to air for a 5 min recovery period. Similarly for CO 2 sensitivity, after 5 min in air the animal was exposed in succession to 5 min of 1%, 3% and then 5% CO 2 , balance air. The last 2 min of each 5 min exposure to air and to CO 2 were used for analysis as used previously in (Davis et al., 2006) . Segments of the record that contained apnea were not used to calculate frequency. Minute ventilation in response to 8% O 2 and to graded CO 2 is reported as percent increase relative to the control. Recorded data was analyzed with custom functions in Chart v5.5.6 (AD Instruments, Inc., Colorado Springs, CO, USA). The hypoxia and hypercarbia studies were conducted when the animals were between 9 and 14 months of age.
Analysis
Apnea was defined as interval between breaths (T TOT ) > 1.0 s. Respiratory cycle irregularity score was obtained from absolute (T TOTn À T TOTn+1 )/T TOTn+1 , and is expressed as the variance (Viemari et al., 2005) . Results are given as mean ± SEM. Inspiratory time (T I ), expiratory time (T E ) and their sum (T TOT ) as well as V T were determined from representative segments of 100 consecutive breaths (Fig. 1 ) using custom functions in Igor Pro Ò (WaveMetrics, Inc. Lake Oswego, OR, USA). Single comparisons between genotypes such as for brain weight and baseline respiratory parameters were analyzed with unpaired student t-tests. The relative effect of hypoxia and CO 2 on T I compared to T E within strains was determined with paired t-tests. Repeated measurements, such as for the three levels of CO 2 , were made with a mixed model analysis of variance (ANOVA) with percentage CO 2 as the repeated measure and genotype as the between group factor. Significance was determined using Sigma stat 3.1 programs with P < 0.05.
RESULTS

Animal characteristics
Mecp2
T158A/+ (n = 8) and Mecp2 +/+ (n = 8) female mice were studied at monthly intervals from 4 months to a year of age. Average weight, 29.3 ± 1.1 gms, of the mutant mice did not differ from that of wild-type animals, 27.1 ± 1.8 g (t = 1.034, p = 0.32, unpaired t-test). As is characteristic of Mecp2 null mice, brain weights at 12 to 14 months of age were significantly smaller in Mecp2 T158A/+ than Mecp2 +/+ controls (432 ± 5 vs. 500 ± 9 mg; t = 6.508, p < 0.0001). Studies in Mecp2 R168X/+ female mice (n = 8) started at ages between 11.5 and 12.4 months and continued to 15.5 months. Body weight in Mecp2 R168X/+ mice was not statistically different from wild type at 12.5 months (22.6 ± 0.7 vs. 24.4 ± 0.7 g, respectively). Similar to Mecp2 T158A/+ , the brain weights of Mecp2 R168X/+ mice were reduced compared to Mecp2 +/+ controls (396 ± 5 vs. 450 ± 6 mg; t = À7.052, p < 0.0001).
Respiratory pattern in Mecp2
T158A/+ and Mecp2 R168X/+ mice All eight Mecp2 T158A/+ animals exhibited an increased incidence of apnea (Figs. 1 and 2A) that occurred between 5.6 and 10.8 months of age (mean: 7.7 ± 0.7 months); although the age at onset varied between mice. Increased apnea incidence did not persist, rather the rates returned to a level that did not differ from that in Mecp2 +/+ mice within 1 month in five Mecp2 T158A/+ mice and within 2 months in the remaining three Mecp2 T158A/+ mice. Since the onset of apnea did not occur at the same age in individual Mecp2 T158A/+ mice, we normalized the peak incidence across age and plotted apnea rates in the months preceding and following the peak ( Fig. 2A) . Breath interval irregularity at the time of peak apnea incidence was significantly greater in Mecp2 Fig. 2B ), but not in the months preceding or following peak incidence (data not shown). Baseline T E in Mecp2 T158A/+ mice was significantly prolonged compared to WT, but T I , T TOT and frequency were not significantly different ( Fig. 2C and Table 1 ).
The respiratory pattern in Mecp2 R168X/+ mice was followed from 11.5 to 15.5 months. Due to age variation in the acquired Mecp2 R168X/+ cohort, respiration was assessed in five Mecp2 R168X/+ mice at 11.5 months and in eight mice at 12.5 months and after. Respiration in wild type mice (n = 7) from the R168X colony was determined at 11.5 and 14.5 months. The incidence of apnea in wild type mice at 11.5 months (9.7 ± 5.3/h) and 14.5 months (1.6 ± 0.9/h) was compared to apnea in Mecp2 R168X/+ at 11.5 and 12.5 months and 13.5, 14.5 and 15.5 months, respectively. At 11.5 months, apnea was greater in all Mecp2 R168X/+ (Figs. 1 and 3A) than wild type and remained elevated throughout all 5 months of assessment (F = 10.6, p = 0.0004 for 11.5-12.5 months and F = 3.59, p = 0.041 for 13.5-15.5 months). Furthermore, inter-breath interval was irregular (F = 16.67, p = 0.013) (Fig. 3B ). Mecp2 R168X/+ mice show significantly prolonged T I , T E and T TOT and significantly reduced frequency (F = 51.71, p < 0.0001) relative to wild-type littermates (Table 1 and Fig. 3C ).
In marked contrast to Mecp2 T158A/+ mice, the incidence of apnea in Mecp2 R168X/+ animals was significantly greater (41 ± 5 vs. 189 ± 43/h; t = 69.55 p = < 0.0001; unpaired t-test). The irregular breathing patterns and decreased frequency were also more severely affected in Mecp2 R168X/+ mice, relative to wild type, than in Mecp2 T158A/+ animals. Irregularity was 7.2 ± 0.7-fold greater than wild type in Mecp2 R168X/+ compared to 3.5 ± 0.4 in Mecp2 T158A/+ (t = 1.55, p = 0.016; unpaired t-test). Respiratory frequency was significantly lower in Mecp2 R168X/+ (0.59 ± 0.04 that of wild type) than in Mecp2 T158A/+ (0.92 ± 0.05 that of wild type) (t = 5.43, p = 0.0001; unpaired t-test).
Hypoxic ventilatory response in Mecp2
T158A/+ and Mecp2 R168X/+ mice
The hypoxic ventilatory response was augmented in females with both the T158A and R168X MeCP2 mutation. Mecp2 T158A/+ and Mecp2 R168X/+ heterozygous females exhibited an increase in minute ventilation in the first minute of breathing 8% oxygen that significantly exceeded that of wild type mice (Figs. 4A, B and 5). The greater increase in minute ventilation was entirely due to a larger increase in respiratory rate in heterozygous females with no difference in V T (Fig. 5) . On return to air, after the 5 min hypoxic exposure, ventilation remained elevated in Mecp2 T158A/+ and Mecp2 R168X/+ mice while it rapidly returned to baseline in wild type mice (Fig. 4) . Additionally, respiratory frequency in Mecp2 +/+ mice decreased below that of the pre-hypoxia baseline (Fig. 5) , a characteristic of rodents termed post-hypoxic frequency decline (Dick and Coles, 2000) . In the 1st minute of recovery, frequency fell 22 ± 8 bpm in wild-type while it remained elevated 17 ± 7 bpm above baseline in Mecp2 T158A/+ animals (F = 4.757; p = 0.047). Similarly in Mecp2 R168X/+ mice respiratory frequency was 31 ± 23 bpm above baseline in the 1st min of recovery while it fell 38 ± 18 bpm in wild type (F = 5.66; p = 0.037). Moreover, the decrease in frequency during recovery in wild-type mice tended to be due to longer T E s than at baseline (T E : 30 ± 7% for T158A Mecp2 +/+ and 35.5 ± 18.9% for R168X Mecp2 +/+ ) than in lengthened T I s (T I : 12.6 ± 4.2% for T158A Mecp2 +/+ and 21.9 ± 17.3% for R168X Mecp2 +/+ ).
CO 2 chemosensitivity in Mecp2 T158A/+ and Mecp2 R168X/+ mice
Chemosensitivity was depressed in both Mecp2
T158A/+ and Mecp2 R168X/+ mice. The relative increase in minute ventilation in both mutant strains was significantly less at 1%, 3% and 5% CO 2 (Fig. 6 ) (Mecp2 T158A : F = 20.589; p < 0.0001 and Mecp2 R168X : F = 21.81; p < 0.0001). The depression was mostly pronounced at 1% CO 2 (71.4%) compared to that at 3% and 5% (55.8% and 55.5%, respectively) in Mecp2 T158A/+ mice. In Mecp2 R168X/+ mice, depression at the lowest CO 2 was also most prominent, 78.2% at 1% CO 2 compared to 51.2% and 30.2% at 3% and 5% CO 2 , respectively. In general, wild type mice showed increased respiratory rate and V T above baseline at all levels of CO 2 (Fig. 7) . In contrast, respiratory rate only increased at 5% CO 2 in Mecp2 T158A/+ and Mecp2 R168X/+ mice (Fig. 7) . CO 2 did not elicit an increase in V T in any CO 2 level in mutant animals (Fig. 7) . In comparison to wild type mice, the increase in frequency for Mecp2 T158A/+ mice tended to be less at 3% CO 2 and was significantly less at 5% CO 2 , while it was significantly less in Mecp2 R168X/+ at 3% CO 2 (Fig. 7) .
The increase in respiratory rate at 5% CO 2 across strains and genotypes was mainly the result of a significant shortening of T E as compared to T I . T E was shortened to a greater extent than TI in Mecp2 T158A/+ (16.7 ± 0.9% vs. 11.6 ± 1.6%; t = 3.196, p = 0.015, paired t-test) and Mecp2 R168X/+ heterozygous females (23 ± 5.6% vs. 12.2 ± 4.3%; t = 3.11, p = 0.021) as well as their wild-type littermates (T158A Mecp2 +/+ :18.1 ± 2.9% vs. 10.7 ± 2.5%; t = 3.716, p = 0.0075 and R168X Mecp2 +/+ : 25.9 ± 2.4% vs.14.6 ± 3.1%; t = 5.11, p = 0.002).
DISCUSSION
The principal findings in this study are that heterozygous female mice with RTT mutation MeCP2 T158A: (1) develop a modest increase in the incidence of apnea between 5.6 and 10.8 months of age, followed by a normal breathing pattern thereafter; (2) have an augmented hypoxic ventilatory response and (3) depressed CO 2 chemosensitivity. In contrast, mice with RTT mutation MeCP2 R168X: (1) have a pronounced incidence of apnea equal to that in Mecp2 null heterozygotes that is sustained from 11.5 through 15.5 months of age and (2) display hypoxic and hypercapnic ventilatory responses similar to Mecp2 T158A/+ mice and Mecp2 null heterozygotes. T158A/+ (3.5-fold) is somewhat less. Differences in apnea incidence and respiratory irregularity between mutation types suggest that the respiratory phenotypes are closely coupled to the functions of MeCP2. While breathing problems are reported to be common in patients with both T158M and R168X mutations (de Lima et al., 2009; Halbach et al., 2012) , a distinction with respect to severity has not been documented in clinical studies.
The divergent respiratory phenotypes of Mecp2 T158A/+ and Mecp2 R168X/+ heterozygous mice share similarities and differences with the phenotype in RTT patients as well as other mouse models of RTT. RTT subjects have . been reported to have irregular breathing and increased respiratory frequency with a significantly shorter T TOT , in which the shortening of T E contributes more than shortening of T I , compared to normal girls (WeeseMayer et al., 2006) . Similar to the irregular breathing patterns reported in RTT subjects, breath-to-breath irregularities were prominent in both the Mecp2 T158A/+ and Mecp2 R168X/+ heterozygous mice. However, the normal respiratory frequency we observed in Mecp2 T158A/+ mice and the decrease in respiratory frequency in Mecp2 R168X/+ mice differ from the human findings. In contrast, an increase in frequency was found in Mecp2
Jae/+ heterozygous female mice (Song et al., 2011; Schmid et al., 2012) . The frequency in Mecp2
Bird/+ heterozygous female mice, on two different background strains, however, was the same as their respective wild type littermates (Samaco et al., 2013) . While breathing irregularity is a common phenotype, respiratory frequency in mouse models of RTT appears to depend on the nature of the MeCP2 mutation.
Prolonged pauses in breathing are another common feature of the respiratory phenotype in RTT. A variety of types of breathing arrests have been reported in awake RTT subjects. Traces of chest wall movement in conjunction with respiration showed that arrest of breathing most commonly occurs at the end of inspiration with the chest wall held in an expanded position or a neutral position (Julu et al., 2001; WeeseMayer et al., 2006; Stettner et al., 2008) . Cheyne-stokes respiration and central apnea are far less common in awake RTT subjects whereby breathing arrest occurs following expiration (Southall et al., 1988; Julu et al., 2001) . The pattern of apnea following expiration in Mecp2 T158A/+ and Mecp2 R168X/+ female mice (Fig. 1 ) differs from the common human observations, indicating that these mice may better model the more uncommonly described apneas.
Two other studies have found an asymptomatic as well as a symptomatic population of Mecp2 deficient female mice (Song et al., 2011; Schmid et al., 2012 ). As noted above both studies used Mecp2 Jae/+ females. Song and co-authors reported that, when studied under anesthesia plus vagotomy, half of the mice were symptomatic, defined as an increase in respiratory frequency. These mice did not have apnea. Schmid et al. examined unanaesthetized mice and found that at 12 weeks of age half had an incidence of apnea that exceeded wild type. These results differ from that we have observed in Mecp2 T158A/+ and Mecp2 R168X/+ mice, all of which were symptomatic. Given that Mecp2 is an X-linked gene, random X-chromosome inactivation (XCI) results in somatic mosaicism and the pattern of XCI likely varies between different cells types and individual subjects. A previous study reported that as many as 72% of neurons may express the wild type allele in the Mecp2 Jae/+ heterozygous mice (Braunschweig et al., 2004) . Thus, unbalanced XCI and/or the XCI state of progenitor cells giving rise to critical cell mass in the brain stem may contribute to the lack of respiratory symptoms in a subpopulation of Mecp2 Jae/+ mice.
The differences in severity of the respiratory phenotype between Mecp2 T158A/+ and Mecp2 R168X/+ female mice are consistent with differences in severity of other behavioral phenotypes. Previous work reported that mice with the MeCP2 T158A mutation develop behavioral phenotypes that are similar to, but less severe than the phenotype of Mecp2 null mice (Goffin et al., 2011) . The MeCP2 T158A protein shows reduced stability and decreased binding to methylated DNA, but retains the ability to interact with co-repressor complexes (Ho et al., 2008; Goffin et al., 2011) . Both the mild respiratory phenotype, described here, and the less severe behavioral phenotype, reported previously, support that T158A is a partial loss-of-function mutation. The R168X mutation, however, results in respiratory abnormalities and a behavioral phenotype more similar, but not identical, to that of Mecp2 null mice (Schaevitz et al., 2013) . The largely truncated R168X protein carries a partial NLS and lacks the TRD domain for interaction with co-repressors (Stancheva et al., 2003; Kumar et al., 2008) . Given that the respiratory phenotype of Mecp2 R168X/+ females is similar to that of Mecp2 Jae/+ or Mecp2 Bird/+ with large deletions of the MBD or MBD and TRD respectively, it suggests that the complete loss of either of these functional domains results in a severe respiratory phenotype. Additionally, it is possible that the truncated R168X protein, though expressed at a low level (Lawson-Yuen et al., 2007) , may have a dominant negative effect on MeCP2 function. Recently, Bird and colleagues reported that mice carrying a MeCP2 R306C missense mutation in the TRD domain, in which the interaction between MeCP2 and NCoR repressor complex is specifically disrupted, develop RTT-like phenotypes (Lyst et al., 2013) , supporting the functional significance of the TRD domain. The respiratory phenotypes in those R306C knockin mice have yet to be characterized.
Unexpectedly Bird/+ mice between 5.5 and 18.5 months of age showed a consistent pattern of apneas (Bissonnette and Knopp, unpublished) (n = 32). While we were only able to follow Mecp2 R168X/+ mice from 11.5 to 15.5 months of age, there were no significant changes in apnea incidence suggesting that, of the mouse models studied to date, the transient increase and improvement in apneas over time may be unique to the Mecp2 T158A/+ heterozygous females. Importantly, in RTT patients, cross sectional observations suggest that abnormal breathing patterns improve with advancing age (Lugaresi et al., 1985; Julu et al., 2001 Bird female (Bissonnette and Knopp, 2006) and male mutant mice (Bissonnette and Knopp, 2006; Voituron et al., 2009; Ward et al., 2011; Ren et al., 2012 ). An increase in excitability of nucleus tractus solitarius (NTS) neurons may underlie the augmented response. Kline and coauthors (Kline et al., 2010) demonstrated that stimulation of the tractus produced larger excitatory post-synaptic currents (EPSCs) in slices from Mecp2 null male mice compared to controls. Bath-applied brain-derived neurotrophic factor (BDNF) reduced the exaggerated EPSCs in the Mecp2-null mice. Furthermore, the absence of a post-hypoxic decline in respiratory frequency (PHFD) (Fig. 4) robustly distinguished both Mecp2 T158A/+ and Mecp2 R168X/+ mice from their respective wild type controls. In wild-type mice, PHFD is mediated mainly through the prolongation of T E compared to baseline as shown previously (Dick and Coles, 2000; Song and Poon, 2009) . PHFD requires intact signaling from neurons in the ventrolateral pons and depends on N-methyl-D-aspartic acid (NMDA) receptor function (Dick and Coles, 2000) . While impaired NMDA receptor signaling has been demonstrated in symptomatic, but not asymptomatic,
Mecp2
Jae/+ female mice (Song et al., 2011) , the extent to which alterations in NMDA function in the ventrolateral pons and EPSCs in the NTS contribute to hypoxic ventilatory response in Mecp2 T158A/+ and Mecp2
R168X/+
mice has yet to be studied.
CO 2 chemosensitivity response is altered in Mecp2 T158A/+ and Mecp2 R168X/+ mice
The depressed hypercapnic ventilatory response displayed by both Mecp2 T158A/+ and Mecp2 R168X/+ is similar to that reported in Mecp2
Bird null male and female heterozygous mice Toward et al., 2013) . Both breath frequency and V T changes were significantly lower in Mecp2
Bird null males than wild types when mice were exposed to low concentrations of CO 2 (1-3%), but not at 6% and 9% CO 2 . Similarly, in this study, the increase in minute ventilation was most depressed at lower CO 2 concentrations ($70% at 1% CO 2 versus 30-50% at 3% and 5% CO 2 ) in both Mecp2 T158A/+ and Mecp2 R168X/+ heterozygous females. The depressed ventilatory response to CO 2 in heterozygous mutants is the result of minimal increases in both respiratory rate and V T as compared to baseline. In wild-type mice of both strains, respiratory rate and V T increased at all levels of CO 2 . In contrast, in Mecp2 T158A/+ and Mecp2 R168X/+ mutant mice, respiratory rate significantly increased only at 5% CO 2 while V T remained unchanged. The increased respiratory frequency demonstrated only at 5% CO 2 in both wild type and heterozygous mutants was the result of decreased T E rather than T I . The blunted chemosensitivity in Mecp2-deficient mice appears to be connected to low levels of the neuromodulators norepinepherine and serotonin. Blocking norepinephrine reuptake markedly improved the response to CO 2 and increasing brain serotonin restored the CO 2 response to the level of wild-type mice (Toward et al., 2013) . Thus, it is likely that elevation of norepinepherine and/or serotonin may restore CO 2 response in Mecp2 T158A/+ and Mecp2 R168X/+ mice as well. During episodes of hyperventilation, CO 2 concentration significantly decreases in RTT subjects (Southall et al., 1988; Smeets et al., 2006) . As in mouse models, if RTT individuals have an elevated CO 2 apnea threshold, they would experience a cessation of breathing at carbon dioxide levels that sustain ventilation in unaffected individuals.
SUMMARY AND CONCLUSIONS
In conclusion this detailed characterization of the respiratory phenotype in heterozygous Mecp2 T158A/+ and Mecp2 R168X/+ mice shows that they share a number of similarities with mice containing large deletions in Mecp2 but with distinct severity. Mice with both T158A and R168X mutations exhibit an increased incidence of apnea, and an irregular breath cycle. The irregular breathing pattern is consistent with what has been found in RTT subjects, but the reduced respiratory frequency in Mecp2 R168X/+ mice and the onset of apnea after expiration in both strains differ from the common breathholding following inspiration in RTT subjects. In addition, we found that abnormal respiration is ameliorated with advancing age in the Mecp2 T158A/+ strain. By comparing Mecp2 T158A/+ mice at their presymptomatic, symptomatic and recovered stages, these mice may prove to be very valuable tools for understanding the pathophysiology of respiratory disorders in RTT. The severe phenotype seen in Mecp2 R168X/+ heterozygous females are well suited for pre-clinical treatment trials that utilize respiration as a primary outcome measure, though classification of individual animal respiratory severity is necessary prior to treatment trials. Furthermore, the augmented hypoxic ventilatory response and depressed hypercapnic response exhibited by both Mecp2 T158A/+ and Mecp2 R168X/+ and previously in mice containing large deletions suggest that these respiratory phenotypes in particular, may be robust outcome measures for preclinical trials.
